Bonjour ,
Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.
% complété
%
2 Ce profil est validé par 2 label.
Company
RTsafe P.C.
32
EQ SCORE L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
Municipality Of Athens, Attica, Greece
Send a message
- 21
employees
- €500,800
turnover
Anglais
RTsafe P.C.
Anglais
RTsafe was established in 2014 to commercialize the internationally patented PseudoPatient® idea. The basic component of which is to build an exact replica of patient’s head to be radiotherapy treated and tested, before his/her actual treatment, aiming to verify and secure the safety and quality of life of the patient treated. PseudoPatient® incorporating point or film detectors has already been awarded (R&D100 award, 1st prize in MIT Enterprise...
RTsafe was established in 2014 to commercialize the internationally patented PseudoPatient® idea. The basic component of which is to build an exact replica of patient’s head to be radiotherapy treated and tested, before his/her actual treatment, aiming to verify and secure the safety and quality of life of the patient treated. PseudoPatient® incorporating point or film detectors has already been awarded (R&D100 award, 1st prize in MIT Enterprise Forum).
In July 2019, our proposal gained the seal-of-excellence under the SME Inst. ph. II. Furthermore, more than 70 related studies have already been published by the RTsafe team members.
Additionally, the PseudoPatient® idea has attracted radiotherapy equipment manufacturers as a means of testing, commissioning and quality assurance (machine QA) tool (using treatment-simulation plans).
The production line is currently based in Athens utilizing 3D printing and CNC technologies.
Since the completion of the 1st funding round in 2017 RTsafe Holding Ltd. was established in Ireland which owns 100% its two subsidiaries: RTsafe P.C. (Greece), and RTsafe Inc. (USA). Company shareholders own shares only of the Holding entity, which owns 100% of the IP rights of the International Patent of the PseudoPatient® offering. Company has achieved to gain – apart from various awards - FDA 510(k) clearance for the US market and is ISO13485 and ISO9001 certified.
Team member(s)
Your request has been sent
Join this organization
Your request has been sent
Our network
Your request has been sent
Join this network
Your message has been sent
Certifications
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not received funding due to budget limits.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1470 Entities
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
332 Entities
Communities
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors.
https://access2eic.eu/
2111 Members
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding
for selected DEEP TECH companies.
1629 Members